Snapshot Life Science

NOT FOR DISTRIBUTION TO UNITED STSTE NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

Disclaimer

The information and options given in this report have been drawn up by Dr Reuter Investor Relations & Europe-Australia IR. The Snapshots have been exclusively published for informative purposes and represents neither a request, quotation nor a recommendation for buying or selling investment instruments or for effecting other transactions. Moreover, neither this publication nor tis information forms the basis for a contract or a commitment of any kind. Any investment in shares, loans and options is faced with risks.

The information and data come from sources which Dr Reuter Investor Relations & Europe-Australia IR considers to be reliable. However, Dr Reuter Investor Relations & Europe-Australia IR do not assume any responsibility for the correctness and completeness of the information and data. Neither the writer nor Dr Reuter Investor Relations & Europe-Australia IR are liable for losses or damage of any kind in connection with the content of these information brochure. By downloading the Snapshots you agree to the provisions previously noted as being mandatory for the recipient. Share prices can vary and corporate value can rise/fall. Any reference to the previous trend in value is not necessarily an indicator of developments to come. Rates of exchange can adversely affect the value trend, price and earnings of any company mentioned here. Reference is also made here to possible political, economic, credit, foreign exchange and market risks. Investment in any of the companies mentioned should only be done after studying the most recent brochure and other company/market information available and/or obtaining appropriate professional advice. Corporate brochures can be obtained from the companies in question. The reader should evaluate any investment in any of the companies mentioned here in the light of their own professional advice, circumstances and investment goals. The recommendation of Dr Reuter Investor Relations & Europe-Australia IR - in the event of any investments - is to consult a qualified professional consultant as to the specific financial risks and the statutory, official, credit, fiscal and settlement, induced consequences. It is quite possible that the issuers of the securities mentioned here have acted at variance to the facts of the case specified herein without Dr Reuter Investor Relations & Europe-Australia IR being aware of this development.

Disclaimer United States:

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES.

This news release does not constitute an offer to sell or other solicitation of an offer to buy any ordinary shares within the United States. The ordinary shares have not been offered and will not be registered under the United States Securities Act of 1933, as amended (the "1933 Act"), or any state securities laws. Accordingly, the ordinary shares may not be offered or sold in the United States or to U.S Persons (as such terms are defined in Regulations S under the 1933 Act) unless registered under the 1933 Act and applicable state securities laws or an exemption from such registration is granted.

Information and investment comments are independently and thoroughly researched and believed correct. No guaranty of absolute accuracy can be given however. Investment decisions are fully made for own risk.

Snapshot LS Nov09